MRI screening for breast cancer in women with familial or genetic predisposition: Design of the Dutch National Study (MRISC)

Familial Cancer

Volumn 1, Issue 3-4, 2001, Pages 163-168

  Kriege, M ^a   Brekelmans, C T M ^a   Boetes, C ^b   Rutgers, E J T ^c   Oosterwijk, J C ^d   Tollenaar, R A E M ^e   Manoliu, R A ^f   Holland, R ^b   De Koning, H J ^a   Klijn, J G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1 2; Breast cancer; High risk; Mammography; MRI; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FAMILIAL CANCER; FEMALE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; PHYSICAL EXAMINATION; POPULATION SURVEILLANCE; RESEARCH DESIGN; RISK FACTORS;

EID: 6444244915     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021135809870     Document Type: Article

References (34)

1. Visser O, Coebergh JWW, Schouten LJ et al. (eds). Incidence of Cancer in The Netherlands 1996. Utrecht: The Netherlands Cancer Registry, 2000.
2. Coebergh JWW, van der Heijden LH, Jansen-Heijnen MLG (eds). Cancer Incidence and Survival in the Southeast of The Netherlands 1955-1994. Eindhoven: The Eindhoven Cancer Registery, 1995.
3. Fletcher SW, Black W, Harris R et al. Report of the international workshop on screening for breast cancer. J Nat Cancer Inst 1993; 85: 1644-56.
4. Tabar L., Fagerberg G, Chen H-H et al. Efficacy of breast cancer screening by age. New results from the Swedish two-country trial. Cancer 1995; 75: 2507-17.
5. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 1340-42.
6. Nyström L, Andersson I, Bjurstam N et al. Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 2002; 359: 909-19.
7. de Koning HJ, Boer R, Warmerdam PG et al. Quantitative interpretation of age-specific mortality reductions from the swedish breast cancer-screening trials. J Nat Cancer Inst 1995; 87: 1217-23.
8. Report of the Organizing Committee and Collaborators, Falun Meeting, Falun, Sweden (21 and 22 March, 1996). Breast-cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996; 68: 693-9.
9. Elmore JG, Barton MB, Moceri VM et al. Ten year risk of false positive screening mammograms and clinical breast examinations. New Eng J Med 1998; 338: 1089-96.
10. Verhoog LC, van den Ouweland AMW, Berns E et al. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. Eur J Cancer 2001; 37: 2082-90.
11. Easton DF, Ford D, Bishop T and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995; 56: 265-71.
12. Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998; 62: 676-89.
13. Brekelmans CTM, Seynaeve C, Bartels CCM et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high family risk. J Clin Oncol 2001; 19: 924-30.
14. Chart PL, Franssen E. Management of women at increased risk for breast cancer: Preliminary results from a new programme. Can Med Assoc J 1997; 157: 1235-42.
15. Lai M-S, Yen M-F, Kuo H-S et al. Efficacy of breast cancer screening for female relatives of breast cancer index cases: Taiwan multicentre cancer screening (TAMCAS). Int J Cancer; 1998: 78, 21-6.
16. Macmillan RD. Screening women with a familial history of breast cancer results from the British Familial Breast Cancer Group. Eur J Surg Oncol; 2000, 26: 149-52.
17. Moller P, Maehle L, Dorum A et al. Inherited breast carcinoma. Prospective findings in 1194 women at risk. Acta Oncol 1996; Supplementum 8: 7-11.
18. Tilanus-Linthorst MMA, Bartels CCM, Obdeijn AIM et al. Earlier detection of breast cancer by surveillance of women at familial risk. Eur J Cancer 2000; 36: 514-19.
19. Kerlikowske K, Carney PA, Geller B et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med 2000; 133:855-63.
20. Kerlikowske K, Grady D, Barclay J et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996; 276: 33-8.
21. Mandelson MT, Oestriecher N, Porter PL et al. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers. J Nat Cancer Inst 2000; 92: 1081-87.
22. Harms SE. Breast Magnetic Resonance Imaging. Seminars in Ultrasound, CT, and MRI 1998; 19: 104-20.
23. Heywang-Kobrunner SH, Viehweg P, Heinig A et al. Contrast-enhanced MRI of the breast; accuracy, value, controversies, solutions. Eur J Radiol 1997; 24: 94-108.
24. Orel SG, Schnall MD. MR Imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001; 220: 13-30.
25. Kuhl CK, Schmutzler RK, Leutner CC et al. Breast MR Imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results. Radiology 2000; 215: 267-79.
26. Meijers-Heijboer H, van Geel B, van Putten WLJ et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. New Eng J Med 2001; 345: 159-64.
27. Stoutjesdijk MJ, Boetes C, Jager GJ et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Nat Cancer Inst 2001; 93: 1095-102.
28. Tilanus-Linthorst MMA, Obdeijn IMM, Bartels CCM et al. First experiences in screening women at high risk for breast cancer with MR imaging. Br Cancer Res Treatm 2000; 63: 53-60.
29. Warner E, Plewes DB, Shumak RS et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001; 19: 3524-31.
30. Brown J, Buckley D, Coulthard A. Magnetic resonance imaging screening in women at genetic risk of breast cancer: Imaging and analysis protocol for the UK multicentre study. Magn Res Imag 2000; 18: 765-76.
31. Bick U. Integriertes früdherkenungskonzept bei frauen mit genetischer prädisposition für burstkrebs. Radiologe 1997; 37: 591-96.
32. van Oortmarssen GJ, Habbema JD, van der Maas PJ et al. A model for breast cancer screening. Cancer 1990; 66: 1601-12.
33. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994; 73: 643-51.
34. Kopans DB, Dórsi CJ, Adler DD et al. Breast Imaging Reporting and Data System (BI-RADS™). 2nd Ed. Reston (VA): American College of Radiology, 1995.